The human body operates on an intrinsic biological clock known as the circadian rhythm, regulating vital physiological ...

A cancer diagnosis has hit very close to home in recent months. It’s likely that cancer has also struck close to most of ...

US FDA accepts for priority review Sanofi’s regulatory submission of tolebrutinib for patients with multiple sclerosis: Paris Wednesday, March 26, 2025, 09:00 Hrs [IST] The US F ...

Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis If approved, tolebrutinib would be the first and only brain-penetrant BTK inhibitor to ...

Tolebrutinib is currently under clinical investigation, and its safety and efficacy have not been evaluated by any regulatory ...

PARIS, France I March 25, 2025 I The US Food and Drug Administration (FDA) is evaluating under priority review the regulatory submission of tolebrutinib to ...

Using 3T MRI to analyze central vein counts and distribution in white matter lesions allows investigators to distinguish ...

While diagnostic criteria for typical multiple sclerosis (MS) perform well in people ages 18 to 50, differential diagnoses in ...

EBV antibodies trigger MS by attacking brain proteins. Genetic factors worsen risk. Breakthrough insights for treatment.

immunology and pathophysiology of multiple sclerosis; neuroimaging and biomarkers; rehabilitation; psychosocial issues; multiple sclerosis collaborative care; gender specific concerns; advocacy issues ...

There are 4 main types of multiple sclerosis (MS), which differ based on how the disease has progressed. The treatment options and long-term outlook can depend on your MS type. Multiple sclerosis ...